Evidence map›Paper›PMID 39963236›Full record

ArticleFrontiers in cellular and infection microbiology2024

Attenuation of acute kidney injury in a murine model of neonatal

Esther M Speer, Atilade A Adedeji, Joyce Lin, Alexandra Khorasanchi, Asma Rasheed, Maya Bhat, Kelly Mackenzie, Randolph Hennigar, Kimberly J Reidy, Robert P Woroniecki

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Esther M SpeerDepartment of Pediatrics, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, United States.
Atilade A AdedejiDepartment of Pediatrics, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, United States.
Joyce LinDepartment of Pediatrics, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, United States.
Alexandra KhorasanchiDepartment of Pediatrics, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, United States.
Asma RasheedDepartment of Pediatrics, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, United States.
Maya BhatDepartment of Pediatrics, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, United States.
Kelly MackenzieDepartment of Chemistry, Stony Brook University, Stony Brook, NY, United States.
Randolph HennigarDepartment of Pathology, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, United States.
Kimberly J ReidyDivision of Pediatric Nephrology, Department of Pediatrics, Children's Hospital at Montefiore, Bronx, NY, United States.
Robert P WoronieckiDepartment of Pediatrics, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, United States.

Funding

Investigating the effect of dysregulated vitamin D metabolism on kidney development following preterm birthR01DK136989 · NIDDK · UNIVERSITY OF VIRGINIA · PI Jennifer R Charlton, Kimberly Jean Reidy · 2024 to 2026
$2.1M
Cell specific Partitioning Defective Par1a/b deletion effects on renal repairR01DK131176 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI REIDY, KIMBERLY JEAN · 2022 to 2025
$1.6M
Bone In CKD Alkali Response Pilot Trial (BICARb Pilot Trial)R01DK131811 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI KUMAR, JUHI, MELAMED, MICHAL L · 2022 to 2024
$1.0M
Immunomodulatory therapy to improve outcomes of neonatal sepsisR21AI149296 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI SPEER, ESTHER MONIKA · 2020 to 2021
$435k
NIAID NIH HHS R21 AI149296NIDDK NIH HHS R01 DK131176NIDDK NIH HHS R01 DK131811NIDDK NIH HHS R01 DK136989
6 · The paper itself

Abstract

Introduction: Sepsis is a risk factor for acute kidney injury (AKI) in neonates, for which no effective treatment exists. The phosphodiesterase inhibitor pentoxifylline (PTX) has demonstrated renal protection from ischemia and inflammation in adult rodents. We hypothesized that addition of PTX to antibiotics may attenuate immune and histological AKI in a murine neonatal sepsis model. Methods: Postnatal (PN) day 1 C57BL/6J mice were injected with Results: Septic mice demonstrated robust expression of pro-inflammatory cytokines, chemokines and biomarkers of tubular injury in renal tissue, which were attenuated in response to combined PTX and antibiotics (gentamicin or cefotaxime): chemokines (p<0.001), plasma (p<0.01) and tissue IL-6 (p<0.05), plasma TNF (p<0.001), NGAL (p<0.01), CXCL10 (p<0.01), osteopontin (p<0.05), and VEGF (p<0.05), with a trend for KIM-1 (tissue concentration: p=0.21, fluorescence area: p=0.12). Interactions between treatment and sex were present for several cytokines and kidney injury biomarkers. Immunofluorescence findings for the tubular injury markers (NGAL and KIM-1) were consistent with biomarker expression in tissue lysates. Conclusion: Neonatal

Indexed as

Acute Kidney InjuryEscherichia coli InfectionsNeonatal SepsisPentoxifyllineSepsisAnimalsAnimals, NewbornAnti-Bacterial AgentsBiomarkersCefotaximeCytokinesDisease Models, AnimalEscherichia coliFemaleGentamicinsKidneyAnti-Bacterial AgentsBiomarkersCefotaximeCytokinesGentamicinsPentoxifyllineacute kidney injury (AKI)anti-inflammatory agentsEscherichia coli sepsisinflammatory responsekidney injury markersneonatal sepsispentoxifylline

Identifiers

PMID39963236
PMCPMC11830670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.